Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...

Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

Everything to Know about Macro and Markets The S&P 500 (SPX) and the Nasdaq-100 (NDX) inched down from Thursday’s record highs, though still ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

The expectation is for Q2 earnings to increase by +5% from the same period last year on +4% higher revenues. This will be a material deceleration from the growth trend of recent quarters and will ...

Jefferies ’ profit declined 40% from a year earlier and per-share earnings fell short of analysts’ expectations, sending the firm’s shares lower by 2.7% in after-hours trading Wednesday.

The Q2 earnings reporting cycle is underway with the peak of the season still to come. It will begin mid-July with the report from JPMorgan Chase & Company (NYSE: JPM), making now a good time to ...